EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Activities of 16-membered ring macrolides and telithromycin against different genotypes of erythromycin-susceptible and erythromycin-resistant Streptococcus pyogenes and Streptococcus pneumoniae



Activities of 16-membered ring macrolides and telithromycin against different genotypes of erythromycin-susceptible and erythromycin-resistant Streptococcus pyogenes and Streptococcus pneumoniae



Journal of Antimicrobial ChemoTherapy 59(6): 1171-1176



Objectives: To test four 16-membered macrolides (josamycin, spiramycin, midecamycin and rokitamycin) along with other compounds in the same class (erythromycin, clarithromycin, roxithromycin and azithromycin) plus clindamycin and telithromycin, against Streptococcus pyogenes and Streptococcus pneumoniae isolates with well-characterized resistance genotypes.Methods: Four hundred and eighty-six isolates of S. pyogenes and 375 isolates of S. pneumoniae were assayed for their macrolide susceptibilities and investigated by PCR to detect their different erythromycin resistance genes. All strains had been isolated over the period 2002-2003 from specimens of different human origin obtained in 14 different Italian centres.Results: All 16-membered macrolides showed very low MICs (MIC(50)s and MIC(90)s, <0.06-0.5 mg/L) for the erythromycin-susceptible isolates and for those with the M phenotype, but the telithromycin MICs for the M-type isolates were at least four times higher (MIC(90)s, 0.5 mg/L). In S. pyogenes, the MIC50S Of 16-membered macrolides for the cMLS(B) isolates were >= 256 mg/L, whereas that for telithromycin was 4 mg/L; the MIC50S of 16-membered macrolides and telithromycin ranged from <= 0.06 to 0.5 mg/L for the iMLS(B) isolates with ern A) and from 0.12 to >= 256 mg/L for those with erm(B). In S. pneumoniae, the MIC(50)s of the 16-membered macrolides for the cMLSB isolates ranged from 0.5 to 128 mg/L, whereas for the iMLSB isolates their values ranged from < 0.06 to 4 mg/L; the MIC(50)s and MIC(90)s of telithromycin for both the cMLS(B) and the iMLS(B) isolates ranged from <0.06 to 0.12 mg/L.Conclusions: MICs ranged for all the drugs, except telithromycin, from <0.06 to >= 256 mg/L, with 15% to 30% resistant S. pyogenes for all drugs tested except clindamycin (8%) and telithromycin (5.4%) and 10% to 40% resistant S. pneumoniae for all drugs tested except telithromycin (0.3%). In both S. pyogenes and S. pneumoniae, erythromycin resistance related to a mef gene meant that telithromycin MICs were definitely higher than in erythromycin-susceptible isolates, although telithromycin susceptibility was preserved in all cases. In S. pyogenes, the activity of both 16-membered macrolides and telithromycin against the iMLS(B) strains proved to be dependent on the erm gene involved, being greater against isolates with erm(A).

(PDF emailed within 0-6 h: $19.90)

Accession: 014948438

Download citation: RISBibTeXText

PMID: 17405779

DOI: 10.1093/jac/dkm089



Related references

Increased activity of 16-membered lactone ring macrolides against erythromycin-resistant Streptococcus pyogenes and Streptococcus pneumoniae: characterization of South African isolates. Journal of Antimicrobial ChemoTherapy 42(6): 729-734, 1999

Activity of telithromycin against erythromycin-susceptible and resistant isolates of Streptococcus pneumoniae and S pyogenes from Austria. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 40: 176, 2000

Activities of a new fluoroketolide, HMR 3787, and its (des)-fluor derivative RU 64399 compared to those of telithromycin, erythromycin A, azithromycin, clarithromycin, and clindamycin against macrolide-susceptible or -resistant Streptococcus pneumoniae and S. pyogenes. Antimicrobial Agents and ChemoTherapy 45(11): 3242-3245, 2001

The post-antibiotic effects of rokitamycin (a 16-membered ring macrolide) on susceptible and erythromycin-resistant strains of Streptococcus pyogenes. International Journal of Antimicrobial Agents 24(3): 254-260, 2004

Characterization of erythromycin-resistant Streptococcus pneumoniae in Korea, and In Vitro activity of telithromycin against erythromycin-resistant Streptococcus pneumoniae. Microbial Drug Resistance 11(3): 260-265, 2005

Activity of telithromycin against susceptible and well characterized erythromycin resistant isolates of Streptococcus pyogenes. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 40: 178, 2000

Increased prevalence of erythromycin resistance in streptococci Substantial upsurge in erythromycin-resistant M phenotype in Streptococcus pyogenes but not in Streptococcus pneumoniae in Taiwan. Microbial Drug Resistance 8(1): 27-33, Spring, 2002

Increased prevalence of erythromycin resistance in streptococci: substantial upsurge in erythromycin-resistant M phenotype in Streptococcus pyogenes (1979-1998) but not in Streptococcus pneumoniae (1985-1999) in Taiwan. Microbial Drug Resistance 8(1): 27-33, 2002

In vitro activity of ketolides telithromycin and HMR 3004 against italian isolates of Streptococcus pyogenes and Streptococcus pneumoniae with different erythromycin susceptibility. Journal of Antimicrobial ChemoTherapy 46(6): 905-908, 2000

In vitro compared activity of telithromycin and azithromycin against northwest Italian isolates of Streptococcus pyogenes and Streptococcus pneumoniae with different erythromycin susceptibility. Letters in Applied Microbiology 47(4): 309-314, 2008

In vitro compared activity of telithromycin and azithromycin against northwest Italian isolates of Streptococcus pyogenes and Streptococcus pneumoniae with different erythromycin susceptibility. Letters in Applied Microbiology 47(4): 309-314, 2009

Activity of telithromycin against erythromycin-susceptible and -resistant Streptococcus pneumoniae isolates from adults with invasive infections. International Journal of Antimicrobial Agents 24(6): 616-618, 2004

Telithromycin is highly active against erythromycin-susceptible and -resistant isolates of Streptococcus pyogenes collected in the United States during the winter 2000/2001. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 41: 190, 2001

In vitro activity of telithromycin against erythromycin-resistant Streptococcus pneumoniae and Streptococcus agalactiae. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 40: 176, 2000

In vitro activities of the ketolides ABT-773 and telithromycin and of three macrolides against genetically characterized isolates of Streptococcus pneumoniae, Streptococcus pyogenes, Haemophilus influenzae and Moraxella catarrhalis. Journal of Antimicrobial ChemoTherapy 50(1): 145-148, 2002